SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK

Supernus Announces FDA Approval of Qelbree® for the Treatment of ADHD in Adults

29 апр 2022 19:00:38 Источник Nasdaq GlobeNewswire

Supernus Reports Final Audited Fourth Quarter and Full Year 2021 Financial Results

13 апр 2022 15:11:14 Источник Nasdaq GlobeNewswire

Supernus Provides Update on Filing of Annual Report and Reiterates Full Year 2022 Financial Guidance

04 апр 2022 16:00:00 Источник Nasdaq GlobeNewswire

Supernus Notifies Nasdaq Regarding Non-Compliance with Listing Requirement and Expectation to Regain Compliance

17 мар 2022 07:30:00 Источник Nasdaq GlobeNewswire

Supernus to Participate in Annual Cowen Health Care Conference

02 мар 2022 07:00:01 Источник Nasdaq GlobeNewswire

Supernus Announces Preliminary Fourth Quarter and Full Year 2021 Financial Results

28 фев 2022 15:05:01 Источник Nasdaq GlobeNewswire

Supernus to Provide Preliminary Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on February 28, 2022

22 фев 2022 15:30:00 Источник Nasdaq GlobeNewswire

Supernus Receives Notice Assigning Early October 2022 PDUFA for SPN-830 Apomorphine Infusion Device NDA

22 фев 2022 07:00:01 Источник Nasdaq GlobeNewswire

Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device

08 дек 2021 07:30:00 Источник Nasdaq GlobeNewswire

Supernus Pharmaceuticals Targeted in Ransomware Incident

24 ноя 2021 17:58:37 Источник Nasdaq GlobeNewswire

Supernus Pharmaceuticals Completes Acquisition of Adamas Pharmaceuticals

24 ноя 2021 08:12:51 Источник Nasdaq GlobeNewswire

Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Adamas Pharmaceuticals Tender Offer

23 ноя 2021 07:00:00 Источник Nasdaq GlobeNewswire

Supernus to Participate in Annual Piper Sandler Healthcare Conference

18 ноя 2021 07:00:02 Источник Nasdaq GlobeNewswire

Supernus to Participate in Upcoming November Investor Conferences

10 ноя 2021 15:05:03 Источник Nasdaq GlobeNewswire

Supernus Announces Third Quarter 2021 Financial Results

03 ноя 2021 15:01:01 Источник Nasdaq GlobeNewswire

Supernus to Announce Third Quarter 2021 Financial Results and Host Conference Call on November 3, 2021

27 окт 2021 16:42:55 Источник Nasdaq GlobeNewswire

Holly Robinson Peete Partners with Supernus to Raise Awareness During ADHD Awareness Month

20 окт 2021 07:00:02 Источник Nasdaq GlobeNewswire

Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product Portfolio

11 окт 2021 05:30:00 Источник Nasdaq GlobeNewswire

Supernus Announces Qelbree™ sNDA for Adult Indication Accepted for Review by FDA

02 сен 2021 17:45:00 Источник Nasdaq GlobeNewswire

Supernus to Participate in Upcoming September Investor Conferences

02 сен 2021 08:00:00 Источник Nasdaq GlobeNewswire